Detalhe da pesquisa
1.
Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer.
Cancer Med
; 11 Suppl 1: 47-53, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36202606
2.
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.
Eur Urol
; 82(2): 212-222, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577646
3.
Adjuvant treatment in lung cancer.
J Clin Transl Res
; 7(2): 175-184, 2021 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34104820
4.
Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial.
Eur Urol Oncol
; 4(3): 456-463, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33612455
5.
Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 18(6): 452-460, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565133
6.
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Nat Med
; 26(6): 983, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32555515
7.
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Nat Med
; 25(11): 1706-1714, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31686036
8.
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Nat Med
; 29(12): 3271, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36944799
9.
Prostate cancer perspectives after chaarted: Optimizing treatment sequence.
Crit Rev Oncol Hematol
; 107: 119-127, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27823639
10.
Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor.
Cancer Treat Rev
; 41(3): 247-53, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25638257
11.
Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: a report of three cases.
Med Oncol
; 29(2): 795-8, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21560067